Nutritional supplements that may be helpful: People with
fibromyalgia often have low serotonin levels in their blood.12 13
14 Supplementation with 5-HTP may increase serotonin
synthesis in these cases. Both preliminary15 16 and double-blind
trials17 have reported that 5-HTP supplementation (100 mg three times per day)
relieves some symptoms of fibromyalgia.
Some studies have found low vitamin B1 (thiamine)
levels and reduced activity of some thiamine-dependent enzymes among people with
fibromyalgia.18 19 The clinical significance of these findings remains
unknown.
One early preliminary study described the use of vitamin
E supplements in the treatment of “fibrositis”—the rough equivalent of
what is today called fibromyalgia. Several dozen individuals were treated with vitamin E using
amounts ranging from 100–300 IU per day. The results were positive and sometimes
dramatic.20 Double-blind trials are needed to confirm these preliminary
observations.
Intravenous S-adenosylmethionine (SAMe) given to people with
fibromyalgia reduced pain and depression in two double-blind trials;21
22 but no benefit was seen in a short (ten-day) trial.23 Oral SAMe (800 mg
per day for six weeks) was tested in one double-blind trial and significant beneficial effects
were seen, such as reduced pain, fatigue, and stiffness, and
improved mood.24
A preliminary trial found that a combination of
magnesium and malic acid might lessen muscle pain in
people with fibromyalgia.25 The amounts used in this trial were 300–600 mg of
elemental magnesium and 1,200–2,400 mg of malic acid per day, taken for eight weeks. A
double-blind trial by the same research group using 300 mg magnesium and 1,200 mg malic acid
per day found no reduction in symptoms, however.26 Though these researchers claimed
that magnesium and malic acid appeared to have some effect at higher levels (up to 600 mg
magnesium and 2,400 mg malic acid), the positive effects were not demonstrated under blinded
study conditions. Therefore, the evidence supporting the use of these supplements for people
with fibromyalgia remains weak and inconclusive.
Melatonin supplementation may be useful in the
treatment of fibromyalgia. In a preliminary trial, 3 mg of melatonin at bedtime was found to
reduce tender points and to improve sleep and other measures of disease severity, though pain
and fatigue improved only slightly.27
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
References:
1. Griep EN, Boersma JW, Lentjes EG, et al. Function of the
hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J
Rheumatol 1998;25:1374–81.
2. Anonymous. Is fibromyalgia caused by a glycolysis impairment? Nutr
Rev 1994;52(7):248–50.
3. Wolfe F, Ross K, Anderson J, Russell J. Aspects of fibromyalgia in the
general population: Sex, pain threshold, and FM symptoms. J Rheumatol
1995;22(1):151–5.
4. Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in
primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol
1989;16(4):527–32.
5. Kaartinen K, Lammi K, Hypen M, et al. Vegan diet alleviates
fibromyalgia symptoms. Scand J Rheumatol 2000;29:308–13.
6. Smith JD, Terpening CM, Schmidt SOF, Gums JG. Relief of fibromyalgia
symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother
2001;35:702–6.
7. Wilke W. Fibromyalgia: Recognizing and addressing the multiple
interrelated factors. Postgrad Med 1996;100(1):153–70.
8. Carette S. Fibromyalgia 20 years later: What have we really
accomplished? J Rheumatol 1995;22(4):590–4.
9. Mengshail AM, Komnaes HB, Forre O. The effects of 20 weeks of physical
fitness training in female patients with fibromyalgia. Clin Exp Rheumatol
1992;10:345–9.
10. Gowans SE, deHueck A, Voss S, Richardson M. A randomized, controlled
trial of exercise and education for individuals with fibromyalgia. Arthritis Care Res
1999;12:120–8.
11. Mannerkorpi K, Nyberg B, Ahlmen M, Ekdahl C. Pool exercise combined
with an education program for patients with fibromyalgia syndrome. A prospective, randomized
study. J Rheumatol 2000;27:2473–81.
12. Fava M, Rosenbaum JF, MacLaughlin R, et al. Neuroendocrine effects of
S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res
1990;24:177–84.
13. Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood
levels in major depression: changes with drug treatment. Acta Neurol Scand
1994;154(suppl):15–8.
14. Bell KM, Potkin SG, Carreon D, Plon L. S-adenosylmethionine blood
levels in major depression: changes with drug treatment. Acta Neurol Scand
1994;154(suppl):15–8.
15. Puttini PS, Caruso I. Primary fibromyalgia syndrome and
5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992;20:182–9.
16. Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in
non-articular rheumatism (“fibrositis syndrome”). Pain
1978;5:65–71.
17. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study
of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J
Int Med Res 1990;18:201–9.
18. Eisinger J, Zakarian H, Plantamura A, et al. Studies of transketolase
in chronic pain. J Adv Med 1992;5:105–13.
19. Eisinger J, Bagneres D, Arroyo P, et al. Effects of magnesium, high
energy phosphates, piracetam, and thiamin on erythrocyte transketolase. Magnesium Res
1994;7(1):59–61.
20. Steinberg CL. The tocopherols (vitamin E) in the treatment of primary
fibrositis. J Bone Joint Surg 1942;24:411–23.
21. Tavoni A, Jeracitano G, Cirigliano G. Evaluation of
S-adenosylmethionine in secondary fibromyalgia: A double-blind study. Clin Exp
Rheumatol 1998;16:106–7 [letter].
22. Tavoni A, Vitali C, Bombardieri S, et al. Evaluation of
S-adenosylmethionine in primary fibromyalgia: A double-blind crossover study. Am J
Med 1987;83(suppl 5A):107–10.
23. Volkmann H, Norregaard J, Jacobsen S, et al. Double-blind,
placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with
fibromyalgia. Scand J Rheumatol 1997;26:206–11.
24. Jacobsen S, Danneskiold-Samsoe B, Andersen RB. Oral
S-adenosylmethionine in primary fibromyalgia: Double-blind clinical evaluation. Scand J
Rheumatol 1991;20:294–302.
25. Abraham G, Flechas J. Management of fibromyalgia: Rationale for the
use of magnesium and malic acid. J Nutr Med 1992;3:49–59.
26. Russell J, Michalek J, Flechas J, et al. Treatment of fibromyalgia
syndrome with SuperMalic: A randomized, double-blind, placebo-controlled, crossover pilot
study. J Rheumatol 1995;22(5):953–7.
27. Citera G, Arias MA, Maldonado-Cocco JA, et al. The effect of
melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol
2000;19:9–13.
28. Kaplan KH, Goldberg DL, Galvin-Naduea M. The impact of a
meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry
1993;15:284–9.
29. Sprott H, Franke S, Kluge H, Hein G. Pain treatment of fibromyalgia
by acupuncture. Rheumatol Int 1998;18:35–6.
30. Waylonis GW. Long-term follow-up on patients with fibrositis treated
with acupuncture. Ohio State Med J 1977;73:299–302.
31. Deluze C, Bosia L, Zirbs A, et al. Electroacupuncture in
fibromyalgia: results of a controlled trial. BMJ 1992;305(6864):1249–52.
32. Berman BM, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in
the treatment of fibromyalgia? J Fam Pract 1999;48:213–8.
33. Wolfe F. The clinical syndrome of fibrositis. Am J Med
1986;81(Supp 3A):7–14.
34. Blunt KL, Moez HR, Rajwani MH, Guerriero RC. The effectiveness of
chiropractic management of fibromyalgia patients: a pilot study. J Manipulative Physiol
Ther 1997;20:389–99.
35. Hains G, Hains F. Combined ischemic compression and spinal
manipulation in the treatment of fibromyalgia; a preliminary estimate of dose and efficacy.
J Manipulative Physiol Ther 2000;23:225–30.